UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations

PLoS medicine, 2007-10, Vol.4 (10), p.1669-79; discussion 1680

2007

Volltextzugriff (PDF)

Differential responses to erlotinib in epidermal growth factor receptor (EGFR)-mutated lung cancers with acquired resistance to gefitinib carrying the L747S or T790M secondary mutations

Journal of clinical oncology, 2008-03, Vol.26 (7), p.1182-1184

2008

Volltextzugriff (PDF)

Efficacy of Pegfilgrastim and Darbepoetin Alfa As Hematopoietic Support for Dose-Dense Every-2-Week Adjuvant Breast Cancer Chemotherapy

Journal of clinical oncology, 2005-11, Vol.23 (33), p.8340-8347

2005

Volltextzugriff (PDF)

Erlotinib-Associated Alopecia in a Lung Cancer Patient

Journal of thoracic oncology, 2007-12, Vol.2 (12), p.1136-1138

2007

Volltextzugriff (PDF)

Three-year survival in metastatic non-small cell lung cancer treated with gefitinib

Lung cancer (Amsterdam, Netherlands), 2006-07, Vol.53 (1), p.123-124

2006

Volltextzugriff (PDF)

Modern treatment of lung cancer: case 3. Non-metastatic bilateral F-18 fluorodeoxyglucose avid adrenal glands in non-small-cell lung cancer

Journal of clinical oncology, 2005-10, Vol.23 (30), p.7740-7742

2005

Volltextzugriff (PDF)

A phase II trial of the Wee1 inhibitor adavosertib (AZD1775) in recurrent uterine serous carcinoma

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.6009-6009

2020

Volltextzugriff (PDF)

Non-metastatic bilateral F-18 fluorodeoxyglucose avid adrenal glands in non-small-cell lung cancer

Journal of clinical oncology, 2005-10, Vol.23 (30), p.7740-7742

2005

Volltextzugriff (PDF)

Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma

Journal of clinical oncology, 2021-05, Vol.39 (14), p.1531-1539

2021

Volltextzugriff (PDF)

Granulosa Cell Tumor of the Ovary

Journal of clinical oncology, 2003-03, Vol.21 (6), p.1180-1189

2003

Volltextzugriff (PDF)

Phase II Study of Avelumab in Patients With Mismatch Repair Deficient and Mismatch Repair Proficient Recurrent/Persistent Endometrial Cancer

Journal of clinical oncology, 2019-10, Vol.37 (30), p.2786-2794

2019

Volltextzugriff (PDF)

A comparison of eDNA sampling methods in an estuarine environment on presence of longfin smelt (Spirinchus thaleichthys) and fish community composition

Environmental DNA (Hoboken, N.J.), 2024-05, Vol.6 (3), p.n/a

2024

Volltextzugriff (PDF)

Urinary Metalloproteinases: Noninvasive Biomarkers for Breast Cancer Risk Assessment

Cancer epidemiology, biomarkers & prevention, 2008-05, Vol.17 (5), p.1034-1042

2008

Volltextzugriff (PDF)

Stepping into survivorship pilot study: Harnessing mobile health and principles of behavioral economics to increase physical activity in ovarian cancer survivors

Gynecologic oncology, 2021-05, Vol.161 (2), p.581-586

2021

Volltextzugriff (PDF)

Abstract PO1-09-10: County-level Social Vulnerability and Survival among Women with Inflammatory Breast Cancer

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO1-09-10-PO1-09-10

2024

Volltextzugriff (PDF)

Abstract PO4-12-11: Patient (pt) time burden with IV vs subcutaneous (SC) administration of trastuzumab/pertuzumab (HP): A time and motion (T+M) substudy of a single arm phase II trial of adjuvant endocrine therapy plus HP for stage I HER2+ breast cancer

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO4-12-11-PO4-12-11

2024

Volltextzugriff (PDF)

Abstract PO2-03-06: Pathological complete response with chemotherapy and immune checkpoint inhibition in triple negative inflammatory breast cancer (TN-IBC)

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO2-03-06-PO2-03-06

2024

Volltextzugriff (PDF)

Phase 2, two-group, two-stage, open-label study of avelumab in patients with microsatellite stable, microsatellite instable and POLE -mutated recurrent or persistent endometrial cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.TPS5615-TPS5615

2017

Volltextzugriff (PDF)

Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein

Virology (New York, N.Y.), 2005-04, Vol.335 (1), p.34-45

2005

Volltextzugriff (PDF)

Induction of CD4+ CD25+ T Regulatory Cells with CD103 Depletion

The Journal of surgical research, 2010-09, Vol.163 (1), p.162-168

2010

Volltextzugriff (PDF)

Decreasing Cycle Time in a Multi-Disciplinary Clinic

Academic pediatrics, 2012-05, Vol.12 (3), p.e16-e16

2012

Volltextzugriff (PDF)

Phase II Trial of Sequential Chemotherapy Followed by Chemoradiation, Surgery, and Postoperative Chemotherapy for the Treatment of Stage IIIA/IIIB Non-Small-Cell Lung Cancer

Clinical lung cancer, 2006-09, Vol.8 (2), p.122-129

2006

Volltextzugriff (PDF)

Descriptive accounts of the behavior of breeding and nonbreeding pairs of golden-bellied mangabeys (Cercocebus galeritus chrysogaster)

Zoo biology, 1987, Vol.6 (4), p.391-399

1987

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(27)
Buchkapitel
(1)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations

Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial

Differential responses to erlotinib in epidermal growth factor receptor (EGFR)-mutated lung cancers with acquired resistance to gefitinib carrying the L747S or T790M secondary mutations

Efficacy of Pegfilgrastim and Darbepoetin Alfa As Hematopoietic Support for Dose-Dense Every-2-Week Adjuvant Breast Cancer Chemotherapy

Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (ADEPT trial)

Erlotinib-Associated Alopecia in a Lung Cancer Patient

Three-year survival in metastatic non-small cell lung cancer treated with gefitinib

Modern treatment of lung cancer: case 3. Non-metastatic bilateral F-18 fluorodeoxyglucose avid adrenal glands in non-small-cell lung cancer

A phase II trial of the Wee1 inhibitor adavosertib (AZD1775) in recurrent uterine serous carcinoma

Non-metastatic bilateral F-18 fluorodeoxyglucose avid adrenal glands in non-small-cell lung cancer

Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma

Granulosa Cell Tumor of the Ovary

Phase II Study of Avelumab in Patients With Mismatch Repair Deficient and Mismatch Repair Proficient Recurrent/Persistent Endometrial Cancer

A comparison of eDNA sampling methods in an estuarine environment on presence of longfin smelt (Spirinchus thaleichthys) and fish community composition

Urinary Metalloproteinases: Noninvasive Biomarkers for Breast Cancer Risk Assessment

Stepping into survivorship pilot study: Harnessing mobile health and principles of behavioral economics to increase physical activity in ovarian cancer survivors

Abstract PO1-09-10: County-level Social Vulnerability and Survival among Women with Inflammatory Breast Cancer

Abstract PO4-12-11: Patient (pt) time burden with IV vs subcutaneous (SC) administration of trastuzumab/pertuzumab (HP): A time and motion (T+M) substudy of a single arm phase II trial of adjuvant endocrine therapy plus HP for stage I HER2+ breast cancer

Abstract PO2-03-06: Pathological complete response with chemotherapy and immune checkpoint inhibition in triple negative inflammatory breast cancer (TN-IBC)

Phase 2, two-group, two-stage, open-label study of avelumab in patients with microsatellite stable, microsatellite instable and POLE -mutated recurrent or persistent endometrial cancer

Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein

Induction of CD4+ CD25+ T Regulatory Cells with CD103 Depletion

Decreasing Cycle Time in a Multi-Disciplinary Clinic

Phase II Trial of Sequential Chemotherapy Followed by Chemoradiation, Surgery, and Postoperative Chemotherapy for the Treatment of Stage IIIA/IIIB Non-Small-Cell Lung Cancer

Descriptive accounts of the behavior of breeding and nonbreeding pairs of golden-bellied mangabeys (Cercocebus galeritus chrysogaster)

Suchergebnisse filtern